Skip to main content
. 2022 Sep 16;10(9):1540. doi: 10.3390/vaccines10091540

Table 3.

Data about coinfections by vaccination status.

Not Vaccinated
n = 1103 (65.4%)
Vaccinated with One Dose
n = 92 (5.5%)
Vaccinated with Two Doses or Monodose
n = 321 (19%)
Vaccinated with Three Doses
n = 170 (10.1%)
p-Value
BSIs 121 (10.9%) 14 (15.2%) 31 (9.6%) 10 (5.9%) 0.09
MDR colonization 86 (7.8%) 7 (7.6%) 16 (4.9%) 8 (4.7%) 0.21
NVP 240 (21.7%) 20 (21.7%) 64 (19.9%) 37 (21.7%) 0.92
UTI 178 (16.1%) 17 (18.5%) 56 (17.4%) 25 (14.7%) 0.81
Clostridioides colitis 8 (0.7%) 1 (1.1%) 2 (0.6%) 3 (1.7%) 0.53
CMV 29 (2.6%) 3 (3.3%) 2 (0.6%) 10 (5.9%) 0.006
EBV 134 (12.1%) 6 (6.5%) 14 (4.4%) 10 (5.9%) <<0.001
HIV 3 (0.3%) - 1 (0.3%) - 0.86
Other respiratory viruses 15 (1.3%) 1 (1.1%) 1 (0.3%) 1 (0.6%) 0.39

MDR, multi drug resistant; NVP, non-viral pneumonia; UTI, urinary tract infection; CMV, cytomegalovirus; EBV: Epstein–Barr virus; HIV: human immunodeficiency virus.